A series of new reports from Jefferies focus on some of the top stocks in the pharmaceutical and biotech arenas. Almost all these stocks have data that could send shares measurably higher.
The May 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The May 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
In an unprecendented move, the U.S. Food and Drug administration (FDA) requested that Endo International remove its Opana ER from the market. Ultimately, the agency held concerns about abuse surrounding the drug.
In an unprecedented move, the FDA has requested that Endo International remove its opioid pain medication from the market. The agency now believes that the benefits of the drug may no longer outweigh its…
Shares of Lexicon Pharmaceuticals saw a hand gain early on Friday after the company reported top-line results from its late-stage trial in type-1 diabetes.
Inovio Pharmaceuticals shares posted a solid gain on Thursday after the company announced that it was beginning its late-stage trial of its treatment for cervical dysplasia caused by human papillomavirus (HPV).
Valeant Pharmaceuticals shares made a solid gain on Thursday after the company announced the sale of its iNova Pharmaceutical business.
NewLink Genetics shares backed off early on Thursday after the company announced that it had regained the rights to its cancer treatment. Newlink shareholders are obviously not happy after missing out on that sweet…
SciClone Pharmaceuticals saw its shares make a solid gain early on Thursday after it was announced that the company entered into a definitive agreement to be acquired by a consortium of companies.
Shares of Novavax saw a handy gain on Wednesday after the company announced updated results from its mid-stage trial for the treatment of the respiratory syncytial virus.
Calithera Biosciences shares made a decent gain early on Wednesday after the company announced that it had been granted a Fast Track Designation by the FDA.
Shares of Inovio Pharmaceuticals saw a handy gain early on Wednesday after the company gave an update on its Zika virus study.
Celldex Therapeutics was another big mover coming out of the Annual Meeting for the American Society of Clinical Oncology (ASCO). Unfortunately, the move was to the downside.
Shares of Albany Molecular Research saw a handy gain on Tuesday after it was announced that the company signed a definitive agreement to be acquired.
